Calls Now Open

2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs

You've just added:

Checkout Go to Cart

May 01, 2017

Advancing a First-in-Class Small Molecule Therapeutic that Inhibits an Enzymatic Regulator of Pathways Essential for the Growth and Spread of Cancer

John Letterio, MD - 2017 Harrington Scholar-Innovator

About the Scholar

John Letterio

Immunology, Neuroscience, Oncology

John Letterio, MD

Case Western Reserve University
Harrington Scholar-Innovator

More about John Letterio

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.